I personally would prefer to reject the offer. The "premium" of 39% is a little misleading given the SP is probably undervalued taking into consideration what's happening over at Tilt and the future projections for CDC (not to mention the other assets).
IFT Price at posting:
$6.80 Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)